Sort
39,280 grants matching “leukemia”
Systems Biology of Tumor Progression and Drug-Resistance
$2,545,749Andrea Califano · Columbia University Health Sciences · RC2 · FY2009 · CA
Shapeshifters in Cancer: Defining the Fundamental Forces of Leukemia Evolution
$2,542,500Dan Landau · Weill Medical Coll Of Cornell Univ · DP2 · FY2018 · CA
Women's Health Initiative Cancer Survivor Cohort
$2,539,856Garnet L. Anderson · Fred Hutchinson Cancer Research Center · UM1 · FY2015 · CA
Selection of Novel Therapies to Ablate Chemoresistant Myeloid Leukemia Stem Cell
$2,535,000Monica L Guzman · Weill Medical Coll Of Cornell Univ · DP2 · FY2010 · OD
(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank
$2,532,382Kathleen Nicol · Research Inst Nationwide Children'S Hosp · U24 · FY2020 · CA
(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank
$2,532,382Kathleen Nicol · Research Inst Nationwide Children'S Hosp · U24 · FY2021 · CA
(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank
$2,532,378Kathleen Nicol · Research Inst Nationwide Children'S Hosp · U24 · FY2025 · CA
DCTD Screening Technologies
$2,528,434David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA
Retroviral Mediated Gene Transfer Into Primate Hematopoietic Cells
$2,523,821Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIC · FY2011 · HL
The Immunobiology of Marrow Allografts for Leukemia
$2,522,446Sloan-Kettering Institute For Cancer Res · P01 · FY2004 · CA
Immunobiology of Allogeneic Hematopoietic Cell Transplantation
$2,522,125Marcel R M Van Den Brink · Sloan-Kettering Inst Can Research · P01 · FY2022 · CA
Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy
$2,519,818Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
ECOG-ACRIN Biospecimen Bank to Support NCTN
$2,515,975Ignacio I. Wistuba · Ecog-Acrin Medical Research Foundation · U24 · FY2020 · CA
Modeling the Role of Differentiation in Cancer Progression
$2,512,726Sylvia Katina Plevritis · Stanford University · U54 · FY2012 · CA
Molecular definition of cancer cell-of-origin
$2,512,500Shangqin Guo · Yale University · DP2 · FY2016 · GM
Novel Cord Blood-Derived Cellular Therapies
$2,508,224Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2019 · CA
Translating Dosage Compensation to Trisomy
$2,507,052Jeanne Bentley Lawrence · Univ Of Massachusetts Med Sch Worcester · RC4 · FY2010 · GM
Brain Tumor Therapeutic Efficacy of Quantitative MR
$2,504,121Brian D. Ross · University Of Michigan At Ann Arbor · P01 · FY2009 · CA
IMPROVING CORD BLOOD TRANSPLANTATION
$2,501,399Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2011 · CA
NCRM Pilot Grant Funding
$2,500,000Mahendra Rao · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2012 · AR
University of Texas M.D. Anderson Cancer SPORE-Leukemia
$2,500,000University Of Texas Md Anderson Can Ctr · P50 · FY2003 · CA
Transcription and Splicing Dynamics in Single Cells
$2,494,706Daniel Larson · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Reducing Disparities in Acute Leukemia (REDIAL) Consortium
$2,494,110Maria Monica Gramatges · Baylor College Of Medicine · U54 · FY2025 · CA
University of Texas M.D. Anderson Cancer SPORE-Leukemia
$2,493,302University Of Texas Md Anderson Can Ctr · P50 · FY2004 · CA
IMPROVING CORD BLOOD TRANSPLANTATION
$2,492,597Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA